Industry Research Reports

Home > Reports > Pharma & Healthcare > Psoriatic Arthritis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Psoriatic Arthritis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 100 Pages

Report ld: 2340363

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Psoriatic Arthritis Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Psoriatic Arthritis Drugs by region & country, by Type, and by Application.

The Psoriatic Arthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Drugs.

Market Segmentation

Report Metric
Details
Report Title
Psoriatic Arthritis Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Psoriatic Arthritis Drugs Companies Covered
Abbvie, Janssen, Amgen, Pfizer, Eli-Lilly, Celgene
Global Psoriatic Arthritis Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Psoriatic Arthritis Drugs Market, Segment by Type
TNF Inhibitors

PDE4 Inhibitors

Interleukin Blockers

Other
Global Psoriatic Arthritis Drugs Market, Segment by Application
Mild Psoriatic Arthritis

Moderate Psoriatic Arthritis

Severe Psoriatic Arthritis
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Psoriatic Arthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Psoriatic Arthritis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Psoriatic Arthritis Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Psoriatic Arthritis Drugs Product Introduction
    1.2 Global Psoriatic Arthritis Drugs Market Size Forecast
        1.2.1 Global Psoriatic Arthritis Drugs Sales Value (2019-2030)
        1.2.2 Global Psoriatic Arthritis Drugs Sales Volume (2019-2030)
        1.2.3 Global Psoriatic Arthritis Drugs Sales Price (2019-2030)
    1.3 Psoriatic Arthritis Drugs Market Trends & Drivers
        1.3.1 Psoriatic Arthritis Drugs Industry Trends
        1.3.2 Psoriatic Arthritis Drugs Market Drivers & Opportunity
        1.3.3 Psoriatic Arthritis Drugs Market Challenges
        1.3.4 Psoriatic Arthritis Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Psoriatic Arthritis Drugs Players Revenue Ranking (2023)
    2.2 Global Psoriatic Arthritis Drugs Revenue by Company (2019-2024)
    2.3 Global Psoriatic Arthritis Drugs Players Sales Volume Ranking (2023)
    2.4 Global Psoriatic Arthritis Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Psoriatic Arthritis Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Psoriatic Arthritis Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Psoriatic Arthritis Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Psoriatic Arthritis Drugs
    2.9 Psoriatic Arthritis Drugs Market Competitive Analysis
        2.9.1 Psoriatic Arthritis Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Psoriatic Arthritis Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 TNF Inhibitors
        3.1.2 PDE4 Inhibitors
        3.1.3 Interleukin Blockers
        3.1.4 Other
    3.2 Global Psoriatic Arthritis Drugs Sales Value by Type
        3.2.1 Global Psoriatic Arthritis Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Psoriatic Arthritis Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Psoriatic Arthritis Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Psoriatic Arthritis Drugs Sales Volume by Type
        3.3.1 Global Psoriatic Arthritis Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Psoriatic Arthritis Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Psoriatic Arthritis Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Psoriatic Arthritis Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Mild Psoriatic Arthritis
        4.1.2 Moderate Psoriatic Arthritis
        4.1.3 Severe Psoriatic Arthritis
    4.2 Global Psoriatic Arthritis Drugs Sales Value by Application
        4.2.1 Global Psoriatic Arthritis Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Psoriatic Arthritis Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Psoriatic Arthritis Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Psoriatic Arthritis Drugs Sales Volume by Application
        4.3.1 Global Psoriatic Arthritis Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Psoriatic Arthritis Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Psoriatic Arthritis Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Psoriatic Arthritis Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Psoriatic Arthritis Drugs Sales Value by Region
        5.1.1 Global Psoriatic Arthritis Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Psoriatic Arthritis Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Psoriatic Arthritis Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Psoriatic Arthritis Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Psoriatic Arthritis Drugs Sales Volume by Region
        5.2.1 Global Psoriatic Arthritis Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Psoriatic Arthritis Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Psoriatic Arthritis Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Psoriatic Arthritis Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Psoriatic Arthritis Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Psoriatic Arthritis Drugs Sales Value, 2019-2030
        5.4.2 North America Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Psoriatic Arthritis Drugs Sales Value, 2019-2030
        5.5.2 Europe Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Psoriatic Arthritis Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Psoriatic Arthritis Drugs Sales Value, 2019-2030
        5.7.2 South America Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Psoriatic Arthritis Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Psoriatic Arthritis Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Psoriatic Arthritis Drugs Sales Value
        6.2.1 Key Countries/Regions Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Psoriatic Arthritis Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.3.2 United States Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.4.2 Europe Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.5.2 China Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.6.2 Japan Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.7.2 South Korea Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Psoriatic Arthritis Drugs Sales Value, 2019-2030
        6.9.2 India Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Psoriatic Arthritis Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbvie
        7.1.1 Abbvie Company Information
        7.1.2 Abbvie Introduction and Business Overview
        7.1.3 Abbvie Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Abbvie Psoriatic Arthritis Drugs Product Offerings
        7.1.5 Abbvie Recent Development
    7.2 Janssen
        7.2.1 Janssen Company Information
        7.2.2 Janssen Introduction and Business Overview
        7.2.3 Janssen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Janssen Psoriatic Arthritis Drugs Product Offerings
        7.2.5 Janssen Recent Development
    7.3 Amgen
        7.3.1 Amgen Company Information
        7.3.2 Amgen Introduction and Business Overview
        7.3.3 Amgen Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Amgen Psoriatic Arthritis Drugs Product Offerings
        7.3.5 Amgen Recent Development
    7.4 Pfizer
        7.4.1 Pfizer Company Information
        7.4.2 Pfizer Introduction and Business Overview
        7.4.3 Pfizer Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Pfizer Psoriatic Arthritis Drugs Product Offerings
        7.4.5 Pfizer Recent Development
    7.5 Eli-Lilly
        7.5.1 Eli-Lilly Company Information
        7.5.2 Eli-Lilly Introduction and Business Overview
        7.5.3 Eli-Lilly Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Eli-Lilly Psoriatic Arthritis Drugs Product Offerings
        7.5.5 Eli-Lilly Recent Development
    7.6 Celgene
        7.6.1 Celgene Company Information
        7.6.2 Celgene Introduction and Business Overview
        7.6.3 Celgene Psoriatic Arthritis Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Celgene Psoriatic Arthritis Drugs Product Offerings
        7.6.5 Celgene Recent Development

 8 Industry Chain Analysis
    8.1 Psoriatic Arthritis Drugs Industrial Chain
    8.2 Psoriatic Arthritis Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Psoriatic Arthritis Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Psoriatic Arthritis Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Psoriatic Arthritis Drugs Market Trends
    Table 2. Psoriatic Arthritis Drugs Market Drivers & Opportunity
    Table 3. Psoriatic Arthritis Drugs Market Challenges
    Table 4. Psoriatic Arthritis Drugs Market Restraints
    Table 5. Global Psoriatic Arthritis Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Psoriatic Arthritis Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Psoriatic Arthritis Drugs Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Psoriatic Arthritis Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Psoriatic Arthritis Drugs Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Psoriatic Arthritis Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Psoriatic Arthritis Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Psoriatic Arthritis Drugs
    Table 13. Global Psoriatic Arthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriatic Arthritis Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Psoriatic Arthritis Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Psoriatic Arthritis Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Psoriatic Arthritis Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Psoriatic Arthritis Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Psoriatic Arthritis Drugs Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Psoriatic Arthritis Drugs Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Psoriatic Arthritis Drugs Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Psoriatic Arthritis Drugs Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Psoriatic Arthritis Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Psoriatic Arthritis Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Psoriatic Arthritis Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Psoriatic Arthritis Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Psoriatic Arthritis Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Psoriatic Arthritis Drugs Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Psoriatic Arthritis Drugs Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Psoriatic Arthritis Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Psoriatic Arthritis Drugs Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Psoriatic Arthritis Drugs Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Psoriatic Arthritis Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Psoriatic Arthritis Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Psoriatic Arthritis Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Psoriatic Arthritis Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Psoriatic Arthritis Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Psoriatic Arthritis Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Psoriatic Arthritis Drugs Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Psoriatic Arthritis Drugs Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Psoriatic Arthritis Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Psoriatic Arthritis Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Psoriatic Arthritis Drugs Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Psoriatic Arthritis Drugs Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Psoriatic Arthritis Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Psoriatic Arthritis Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Psoriatic Arthritis Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Psoriatic Arthritis Drugs Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Psoriatic Arthritis Drugs Sales Volume, (2025-2030) & (K MT)
    Table 57. Abbvie Company Information
    Table 58. Abbvie Introduction and Business Overview
    Table 59. Abbvie Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Abbvie Psoriatic Arthritis Drugs Product Offerings
    Table 61. Abbvie Recent Development
    Table 62. Janssen Company Information
    Table 63. Janssen Introduction and Business Overview
    Table 64. Janssen Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Janssen Psoriatic Arthritis Drugs Product Offerings
    Table 66. Janssen Recent Development
    Table 67. Amgen Company Information
    Table 68. Amgen Introduction and Business Overview
    Table 69. Amgen Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Amgen Psoriatic Arthritis Drugs Product Offerings
    Table 71. Amgen Recent Development
    Table 72. Pfizer Company Information
    Table 73. Pfizer Introduction and Business Overview
    Table 74. Pfizer Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Pfizer Psoriatic Arthritis Drugs Product Offerings
    Table 76. Pfizer Recent Development
    Table 77. Eli-Lilly Company Information
    Table 78. Eli-Lilly Introduction and Business Overview
    Table 79. Eli-Lilly Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Eli-Lilly Psoriatic Arthritis Drugs Product Offerings
    Table 81. Eli-Lilly Recent Development
    Table 82. Celgene Company Information
    Table 83. Celgene Introduction and Business Overview
    Table 84. Celgene Psoriatic Arthritis Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Celgene Psoriatic Arthritis Drugs Product Offerings
    Table 86. Celgene Recent Development
    Table 87. Key Raw Materials Lists
    Table 88. Raw Materials Key Suppliers Lists
    Table 89. Psoriatic Arthritis Drugs Downstream Customers
    Table 90. Psoriatic Arthritis Drugs Distributors List
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Psoriatic Arthritis Drugs Product Picture
    Figure 2. Global Psoriatic Arthritis Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Psoriatic Arthritis Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Psoriatic Arthritis Drugs Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Psoriatic Arthritis Drugs Sales Price (2019-2030) & (USD/MT)
    Figure 6. Psoriatic Arthritis Drugs Report Years Considered
    Figure 7. Global Psoriatic Arthritis Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Psoriatic Arthritis Drugs Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Psoriatic Arthritis Drugs Revenue in 2023
    Figure 10. Psoriatic Arthritis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. TNF Inhibitors Picture
    Figure 12. PDE4 Inhibitors Picture
    Figure 13. Interleukin Blockers Picture
    Figure 14. Other Picture
    Figure 15. Global Psoriatic Arthritis Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Psoriatic Arthritis Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Psoriatic Arthritis Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 18. Global Psoriatic Arthritis Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Psoriatic Arthritis Drugs Price by Type (2019-2030) & (USD/MT)
    Figure 20. Product Picture of Mild Psoriatic Arthritis
    Figure 21. Product Picture of Moderate Psoriatic Arthritis
    Figure 22. Product Picture of Severe Psoriatic Arthritis
    Figure 23. Global Psoriatic Arthritis Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 24. Global Psoriatic Arthritis Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 25. Global Psoriatic Arthritis Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 26. Global Psoriatic Arthritis Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 27. Global Psoriatic Arthritis Drugs Price by Application (2019-2030) & (USD/MT)
    Figure 28. North America Psoriatic Arthritis Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 29. North America Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 30. Europe Psoriatic Arthritis Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 31. Europe Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 32. Asia Pacific Psoriatic Arthritis Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 34. South America Psoriatic Arthritis Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 35. South America Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 36. Middle East & Africa Psoriatic Arthritis Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 37. Middle East & Africa Psoriatic Arthritis Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 38. Key Countries/Regions Psoriatic Arthritis Drugs Sales Value (%), (2019-2030)
    Figure 39. Key Countries/Regions Psoriatic Arthritis Drugs Sales Volume (%), (2019-2030)
    Figure 40. United States Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 41. United States Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 42. United States Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 43. Europe Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Europe Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 45. Europe Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 46. China Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 47. China Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 48. China Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 49. Japan Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Japan Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 51. Japan Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 52. South Korea Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 53. South Korea Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 54. South Korea Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 55. Southeast Asia Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 56. Southeast Asia Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 57. Southeast Asia Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 58. India Psoriatic Arthritis Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 59. India Psoriatic Arthritis Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 60. India Psoriatic Arthritis Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 61. Psoriatic Arthritis Drugs Industrial Chain
    Figure 62. Psoriatic Arthritis Drugs Manufacturing Cost Structure
    Figure 63. Channels of Distribution (Direct Sales, and Distribution)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed

Description

The global market for Psoriatic Arthritis Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Psoriatic Arthritis Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Psoriatic Arthritis Drugs by region & country, by Type, and by Application.

The Psoriatic Arthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriatic Arthritis Drugs.

Market Segmentation